Hepatitis C virus infection in chronic liver disease in Bombay.
dc.contributor.author | Amarapurkar, D N | en_US |
dc.contributor.author | Kumar, A | en_US |
dc.contributor.author | Parikh, S S | en_US |
dc.contributor.author | Chopra, K B | en_US |
dc.contributor.author | Murti, P | en_US |
dc.contributor.author | Kalro, R H | en_US |
dc.contributor.author | Desai, H G | en_US |
dc.date.accessioned | 1992-10-01 | en_US |
dc.date.accessioned | 2009-05-29T02:30:59Z | |
dc.date.available | 1992-10-01 | en_US |
dc.date.available | 2009-05-29T02:30:59Z | |
dc.date.issued | 1992-10-01 | en_US |
dc.description.abstract | To find out the prevalence of antibody of hepatitis C virus (anti-HCV) in patients with chronic liver disease in Bombay, sera from 126 patients (93 men, 33 women; aged 9-70 years, mean 39.7) with chronic liver disease (cirrhosis 103, cirrhosis with hepatocellular carcinoma 3, chronic active hepatitis 20) were tested for HBsAg and anti-HCV antibody. HBsAg positive sera were tested for anti-delta antibody and IgM anti-HBc. All the tests were carried out by ELISA. Of 126 patients, 51 (40.5%) were HBsAg positive, 49 (38.8%) alcoholic and 21 (16.6%) anti-HCV positive. The prevalence of anti-HCV in HBsAg positive, alcoholic and cryptogenic (HBV negative and no alcohol) liver disease patients was 13.7%, 14.7% and 20.5% respectively. Of 21 anti-HCV antibody positive patients, 8 (38%) had received blood transfusions previously. HCV is present in 15-20% of patients with chronic liver disease in Bombay. | en_US |
dc.description.affiliation | Department of Gastroenterology, B Y L Nair Charitable Hospital, Bombay. | en_US |
dc.identifier.citation | Amarapurkar DN, Kumar A, Parikh SS, Chopra KB, Murti P, Kalro RH, Desai HG. Hepatitis C virus infection in chronic liver disease in Bombay. Indian Journal of Gastroenterology. 1992 Oct; 11(4): 162-3 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/64236 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.indianjgastro.com | en_US |
dc.subject.mesh | Adolescent | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Child | en_US |
dc.subject.mesh | Chronic Disease | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Hepacivirus --immunology | en_US |
dc.subject.mesh | Hepatitis Antibodies --analysis | en_US |
dc.subject.mesh | Hepatitis C --epidemiology | en_US |
dc.subject.mesh | Hepatitis C Antibodies | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | India --epidemiology | en_US |
dc.subject.mesh | Kidney Failure, Chronic --complications | en_US |
dc.subject.mesh | Liver Diseases --microbiology | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.subject.mesh | Renal Dialysis | en_US |
dc.subject.mesh | Seroepidemiologic Studies | en_US |
dc.title | Hepatitis C virus infection in chronic liver disease in Bombay. | en_US |
dc.type | Journal Article | en_US |
dc.type | Research Support, Non-U.S. Gov't | en_US |
Files
License bundle
1 - 1 of 1